---
title: "Helus Pharma (HELP) news: delisting and offering"
url: "https://aibio.space/companies/helus-pharma/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "HELP delisting and offering news: Cybin Inc. (now Helus Pharma) files Form 25 to leave NYSE American. Helus Pharma Inc. (NEO: HELP), Canada."
---

HELP Helus Pharma Inc. NEO · Canada

# Helus Pharma (HELP) news HELP delisting and offering news

Financings · 2026-07-16

## [Helus Pharma (Cybin Inc.) closes US$50 million share offering at US$4.85](https://aibio.space/news/helus-pharma-cybin-inc-closes-us-50-million-share-offering-us-4-85/)

Helus Pharma sold 10,309,280 shares at US$4.85 in an underwritten offering that closed on June 25, 2026. The proceeds are meant partly for a Phase 3 depression program whose data are not due until the fourth quarter.

## Latest Helus Pharma news

1. 2026-01-02 Listings [Cybin Inc. (now Helus Pharma) files Form 25 to leave NYSE American](https://aibio.space/news/cybin-inc-now-helus-pharma-files-form-25-leave-nyse-american/) The January 2, 2026 filing covers the company's common shares. It relies on the SEC rule for a voluntary withdrawal by the issuer.

## Helus Pharma at a glance

- **Ticker**: HELP

- **Listing**: NEO

- **Country**: Canada

- **Cash, Mar 31, 2025**: C$135.0 million

### Related companies

- [Core One Labs](https://aibio.space/companies/core-one-labs/) OTC: CLABF
- [Apotex Health](https://aibio.space/companies/apotex-health/) TSX: APTX
- [Lexaria Bioscience](https://aibio.space/companies/lexaria-bioscience/) NASDAQ: LEXX
- [NORTH BUD FARMS INC](https://aibio.space/companies/north-bud-farms/) OTC: NOBDF
- [Devonian Health Group](https://aibio.space/companies/devonian-health/) TSXV: GSD
- [Arch Biopartners](https://aibio.space/companies/arch-biopartners/) TSXV: ARCH
- [PharmaTher Holdings](https://aibio.space/companies/pharmather/) CSE: PHRM
- [Modern Mobility Aids](https://aibio.space/companies/modern-mobility-aids/) OTC: MDRM

### Also on NEO

- [Onco-Innovations](https://aibio.space/companies/onco-innovations/) ONCO

## Helus Pharma annual financials

| Line | FY ended Mar 31, 2025 | FY ended Mar 31, 2024 |
|---|---|---|
| Research and development | [C$54.9 million](https://www.sec.gov/Archives/edgar/data/1833141/000162828025033606/) | [C$32.4 million](https://www.sec.gov/Archives/edgar/data/1833141/000162828025033606/) |
| Net income (loss) | [-C$113.1 million](https://www.sec.gov/Archives/edgar/data/1833141/000162828025033606/) | [-C$78.1 million](https://www.sec.gov/Archives/edgar/data/1833141/000162828025033606/) |
| Cash from operations | [-C$101.3 million](https://www.sec.gov/Archives/edgar/data/1833141/000162828025033606/) | [-C$68.9 million](https://www.sec.gov/Archives/edgar/data/1833141/000162828025033606/) |
| Cash and equivalents | [C$135.0 million](https://www.sec.gov/Archives/edgar/data/1833141/000162828025033606/) | [C$209.0 million](https://www.sec.gov/Archives/edgar/data/1833141/000162828025033606/) |

Latest balance sheet, Mar 31, 2025 (40-F): cash and equivalents C$135.0 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about Helus Pharma

Was Helus Pharma delisted?

Our latest story on this, dated Jan 2, 2026: "Cybin Inc. (now Helus Pharma) files Form 25 to leave NYSE American". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/cybin-inc-now-helus-pharma-files-form-25-leave-nyse-american/).

Has Helus Pharma raised money recently?

Our latest story on this, dated Jul 16, 2026: "Helus Pharma (Cybin Inc.) closes US$50 million share offering at US$4.85". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/helus-pharma-cybin-inc-closes-us-50-million-share-offering-us-4-85/).

What is the ticker symbol of Helus Pharma?

Helus Pharma Inc. trades under the ticker HELP on NEO.

Where is Helus Pharma listed?

Helus Pharma Inc. is listed on NEO. Our directory also records these other listings: GETTEX:R7E0; LS:A42NG7; LSX:A42NG7; NASDAQ:HELP.

What is the SEC CIK of Helus Pharma?

The SEC Central Index Key (CIK) for Helus Pharma Inc. is 1833141. Its filings are on SEC EDGAR.

Which country or territory is Helus Pharma listed under?

Our directory records Helus Pharma Inc. under Canada.

What does Helus Pharma do?

Our directory classifies Helus Pharma Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Helus Pharma?

The ISIN recorded for Helus Pharma Inc. is CA4234921076.

Does aibio.space cover Helus Pharma?

aibio.space lists Helus Pharma Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is Helus Pharma incorporated?

SEC records list its state or country of incorporation as A1.

What is the latest Helus Pharma (HELP) stock news?

Our latest story on Helus Pharma, dated Jul 16, 2026: "Helus Pharma (Cybin Inc.) closes US$50 million share offering at US$4.85". Helus Pharma sold 10,309,280 shares at US$4.85 in an underwritten offering that closed on June 25, 2026. The proceeds are meant partly for a Phase 3 depression program whose data are not due until the fourth quarter. [Source](https://aibio.space/news/helus-pharma-cybin-inc-closes-us-50-million-share-offering-us-4-85/).

Is Helus Pharma a smaller reporting company?

SEC records list Helus Pharma Inc.'s filer category as: <br>Emerging growth company.

Where is Helus Pharma headquartered?

SEC records list its business address as 100 KING STREET WEST, TORONTO.

When does Helus Pharma's fiscal year end?

Helus Pharma Inc.'s fiscal year ends on March 31, per SEC records.

What did Helus Pharma last file with the SEC?

Its most recent filing in our record is a 6-K filed 2026-10-21. All of its filings are on SEC EDGAR. [Source](https://www.sec.gov/Archives/edgar/data/1833141/000106299326005468/form6k.htm).

## Investor discussion: Helus Pharma

Members talk about Helus Pharma (HELP). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Helus Pharma, newest first. Each line links the filing it comes from.

1. 2026-07-16 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1833141/000106299326003691/exhibit99-1.htm)
2. 2026-06-25 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1833141/000106299326003338/exhibit99-1.htm)
3. 2026-01-02 Listings Filed to remove its shares from exchange listing. SEC Form 25. [Source](https://www.sec.gov/Archives/edgar/data/1833141/000106299326000002/form25.htm)
4. 2025-12-30 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1833141/000106299325017515/exhibit99-1.htm)
5. 2025-10-29 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1833141/000106299325016352/exhibit99-1.htm)
6. 2025-07-01 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1833141/000162828025033665/a991-hightrailxregistratio.htm)
7. 2025-02-11 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1833141/000106299325002022/exhibit99-1.htm)

## SEC filings and registration

- **SEC name**: Helus Pharma Inc.

- **CIK**: 1833141

- **Industry (SIC)**: Pharmaceutical Preparations (2834)

- **US tickers**: HELP (Nasdaq)

- **State or country of incorporation**: A1

- **Fiscal year ends**: March 31

- **Filer category**: <br>Emerging growth company

- **Business address**: 100 KING STREET WEST, TORONTO

- **Phone**: (908) 764-8385

- **Former names**: CYBIN INC.

### Recent filings (8-K and 6-K are the company's own announcements)

- [6-K](https://www.sec.gov/Archives/edgar/data/1833141/000106299326005468/form6k.htm) filed 2026-10-21
- [6-K](https://www.sec.gov/Archives/edgar/data/1833141/000183314126000091/heluspharmainc-form6xk10x1.htm) filed 2026-10-15
- [6-K](https://www.sec.gov/Archives/edgar/data/1833141/000183314126000089/heluspharmainc-form6xk10x0.htm) filed 2026-10-08
- [6-K](https://www.sec.gov/Archives/edgar/data/1833141/000106299326005176/form6k.htm) filed 2026-10-05
- [6-K](https://www.sec.gov/Archives/edgar/data/1833141/000183314126000087/heluspharmainc-mcrxform6xk.htm) filed 2026-10-02
- [6-K](https://www.sec.gov/Archives/edgar/data/1833141/000183314126000084/heluspharmainc-form6xk10x0.htm) filed 2026-10-01
- [6-K](https://www.sec.gov/Archives/edgar/data/1833141/000183314126000081/cybininc-form6xkasmresults.htm) filed 2026-09-23
- [6-K](https://www.sec.gov/Archives/edgar/data/1833141/000183314126000078/cybininc-form6xk09x21x20262.htm) filed 2026-09-22

Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001833141), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

## Listing details

Helus Pharma Inc. is a public biotech or pharmaceutical company listed on NEO under the ticker HELP, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Helus Pharma Inc.

- **Ticker**: HELP

- **Listing**: NEO

- **Country or territory**: Canada

- **Business scope**: Pharmaceuticals: Major

- **ISIN**: CA4234921076

- **Other listed symbols**: GETTEX:R7E0; LS:A42NG7; LSX:A42NG7; NASDAQ:HELP

- **Last quote in directory**: 2026-10-21

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/NEO-HELP/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/helus-pharma/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Helus Pharma (HELP) news: delisting and offering", 2026-10-31, https://aibio.space/companies/helus-pharma/